Voyager Therapeutics, Inc.
VYGRNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for VYGR. That does not mean none is planned.
Get an email about VYGR's next catalysts
Track Voyager Therapeutics (VYGR) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming, 1 past
VYGR Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.41 | FQ end Sep/2026 | Call: tbd
Reported a Q3 loss and revenue that lagged analyst estimates, per the Zacks headline; no figures were provided in the article text.
How VYGR's past catalysts played out
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is Voyager Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Voyager Therapeutics, Inc. (VYGR) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track VYGR biotech catalysts?→
Add VYGR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Voyager Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.